Nemaura Medical Inc.
NMRD
$0.0001
-$0.0001-50.00%
OTC PK
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | -10.65M | -10.21M | -12.86M | -14.14M | -13.08M |
Total Depreciation and Amortization | 485.30K | 500.80K | 443.50K | 444.20K | 358.70K |
Total Amortization of Deferred Charges | -477.60K | -758.80K | 584.00K | 1.87M | 5.68M |
Total Other Non-Cash Items | 2.30M | 2.25M | 4.97M | 5.43M | 1.10M |
Change in Net Operating Assets | -1.22M | -1.41M | -1.73M | -2.05M | -2.30M |
Cash from Operations | -9.57M | -9.63M | -8.59M | -8.45M | -8.24M |
Capital Expenditure | -177.20K | -233.60K | -379.70K | -376.10K | -398.10K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.00 | 9.20K | 29.10K | -163.00K | -117.10K |
Cash from Investing | -177.20K | -224.40K | -350.70K | -539.20K | -515.30K |
Total Debt Issued | 6.50M | 6.50M | 0.00 | 4.70M | 4.70M |
Total Debt Repaid | -11.48M | -10.18M | -9.10M | -10.27M | -13.87M |
Issuance of Common Stock | 8.39M | 8.39M | 8.39M | 8.39M | 3.00M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -737.40K | -737.70K | -737.70K | -737.70K | -46.70K |
Cash from Financing | 2.68M | 3.98M | -1.44M | 2.08M | -6.22M |
Foreign Exchange rate Adjustments | -138.70K | 141.60K | -358.90K | -735.30K | -729.20K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -7.20M | -5.73M | -10.74M | -7.64M | -15.71M |